DTE
49
16
SO
48
6
AA
27
5
HES
49
2
V
70
14
AIV
39
6
MAR
57
3
AMP
43
2
VMC
41
2
VRSN
59
4
COF
48
3
EMR
57
7
XYL
29
4
NTRS
35
10
DUK
49
4
JNPR
59
3
ZBH
69
15
KSS
36
2
MDT
59
4
IBM
53
2
DTE
49
16
SO
48
6
AA
27
5
HES
49
2
V
70
14
AIV
39
6
MAR
57
3
AMP
43
2
VMC
41
2
VRSN
59
4
COF
48
3
EMR
57
7
XYL
29
4
NTRS
35
10
DUK
49
4
JNPR
59
3
ZBH
69
15
KSS
36
2
MDT
59
4
IBM
53
2
Financhill
Back

PeptiDream 10K Form

Buy
60

PPTDF
PeptiDream

Last Price:
$17.15
Seasonality Move:
-2.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PPTDF News And Ratings

See the #1 stock for the next 7 days that we like better than PPTDF

PPTDF Financial Statistics

Sales & Book Value

Annual Sales: $204.6M
Cash Flow: $173.8M
Price / Cash Flow: 12.97
Annual Sales: $3.16
Price / Book: 5.43

Profitability

EPS (TTM): 0.84160
Net Income (TTM): $109.2M
Gross Margin: $122.7M
Return on Equity: 34.66%
Return on Assets: 20.65%

PeptiDream Earnings Forecast

Key PeptiDream Financial Ratios

  • The Gross Profit Margin over the past 12 years for PPTDF is 59.97%.
  • The Selling, General & Administrative Expenses for PPTDF have been equal to 25.27% of Gross Profit Margin.
  • The Research & Development expenses have been 10.99% of Revenue.
  • The Interest Expense is 74.21% of Operating Income.
  • The Net Earning history of PPTDF is 10.57% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

PeptiDream Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: PPTDF
Website: peptidream.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 3.51
Quick Ratio: 3.28

Price-to-Earnings

Trailing P/E Ratio: 102.92
Forward P/E Ratio: 0

PPTDF Technical Analysis vs Fundamental Analysis

Buy
60
PeptiDream (PPTDF) is a Buy

Is PeptiDream a Buy or a Sell?

  • PeptiDream stock is rated a Buy
    The current PeptiDream [PPTDF] share price is $17.15. The Score for PPTDF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.